- Delgado, Soledad
- Somovilla, Pilar
- Ferrer-Orta, Cristina
- Martínez-González, Brenda
- Vázquez-Monteagudo, Sergi
- Muñoz-Flores, Javier
- Soria, María Eugenia
- García-Crespo, Carlos
- Ávila, Ana Isabel de
- Durán-Pastor, Antoni
- Gadea, Ignacio
- López-Galíndez, Cecilio
- Morán, Federico
- Lorenzo-Redondo, Ramón
- Verdaguer, Núria
- Perales, Celia
- Domingo, Esteban
Since its introduction in the human population, SARS-CoV-2 has evolved into multiple clades, but the events in its intrahost diversification are not well understood. Here, we compare three-dimensional (3D) self-organized neural haplotype maps (SOMs) of SARS-CoV-2 from thirty individual nasopharyngeal diagnostic samples obtained within a 19-day interval in Madrid (Spain), at the time of transition between clades 19 and 20. SOMs have been trained with the haplotype repertoire present in the mutant spectra of the nsp12- and spike (S)-coding regions. Each SOM consisted of a dominant neuron (displaying the maximum frequency), surrounded by a low-frequency neuron cloud. The sequence of the master (dominant) neuron was either identical to that of the reference Wuhan-Hu-1 genome or differed from it at one nucleotide position. Six different deviant haplotype sequences were identified among the master neurons. Some of the substitutions in the neural clouds affected critical sites of the nsp12-nsp8-nsp7 polymerase complex and resulted in altered kinetics of RNA synthesis in an in vitro primer extension assay. Thus, the analysis has identified mutations that are relevant to modification of viral RNA synthesis, present in the mutant clouds of SARS-CoV-2 quasispecies. These mutations most likely occurred during intrahost diversification in several COVID-19 patients, during an initial stage of the pandemic, and within a brief time period., Institutional support from Global Management Solutions and valuable discussions are acknowledged. The work at UPM was supported by grants PID2019-104903RB-100 and PID2022-139908OB-I00, funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. The work at FJD was supported by project PI21/00139 from Instituto de Salud Carlos III, co-funded by the European Union. The work at CSIC was supported by PID2020-113888RB-I00, PID2020-117976GB-I00, and 202220I116 from Ministerio de Ciencia e Innovación and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission – NextGenerationEU (regulation EU 2020/2094), through the CSIC’s Global Health Platform (PTI Salud Global), and Fundació La Marató de TV3 (project 525/C/2021), grants 202136-30 and 202136-31. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). Work at Centro Nacional de Microbiología (ISCIII) was supported by grants SAF2016-77894-R from MINECO and PI13/02269 from ISCIII. The work at Universidad Complutense Madrid has been supported by research grant CTQ2017-87864-C2-2-P, from MINECO. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from ISCIII, cofinanced by Fondo Social Europeo (FSE). A.D.-P. is supported by the contract 13-2022-008566 cofinanced by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union–Next Generation EU. P.S. is supported by postdoctoral contract “Margarita Salas” CA1/RSUE/2021 from MCIU. C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU., Peer reviewed